Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare tumor linked to a dismal prognosis. Even the most effective chemotherapeutical regime of pemetrexed combined with cisplatin leads to a remission-rate of only about 40%. The reasons for the rather poor efficacy remain largely unknown. RESULTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Mairinger, Fabian Dominik, Vollbrecht, Claudia, Flom, Elena, Christoph, Daniel Christian, Schmid, Kurt-Werner, Kollmeier, Jens, Popper, Helmut Hans, Mairinger, Thomas, Henry Walter, Robert Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514925/
https://www.ncbi.nlm.nih.gov/pubmed/28415584
http://dx.doi.org/10.18632/oncotarget.16398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514925/
https://www.ncbi.nlm.nih.gov/pubmed/28415584
http://dx.doi.org/10.18632/oncotarget.16398

Ejemplares similares